naphthalimides has been researched along with Neuralgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Areti, A; Gogoi, R; Komirishetty, P; Kumar, A; Sistla, R | 1 |
| Arora, M; Kaundal, RK; Kumar, A; Sharma, SS | 1 |
2 other study(ies) available for naphthalimides and Neuralgia
| Article | Year |
|---|---|
Combination strategy of PARP inhibitor with antioxidant prevent bioenergetic deficits and inflammatory changes in CCI-induced neuropathy.
Topics: 1-Naphthylamine; Adenosine Triphosphate; Animals; Antioxidants; Encephalitis; Hyperalgesia; Male; Mitochondria; NAD; Naphthalimides; Neuralgia; Oxidative Stress; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quercetin; Quinolones; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2017 |
Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes.
Topics: 1-Naphthylamine; Animals; Antioxidants; Diabetic Neuropathies; Male; Malondialdehyde; NAD; Naphthalimides; Neural Conduction; Neuralgia; Neuroprotective Agents; Oxidative Stress; Pain Measurement; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Quinolones; Rats; Rats, Sprague-Dawley; Resveratrol; Sciatic Nerve; Stilbenes | 2009 |